In 2013, we changed the name of this journal to Artificial Cells, Nanomedicine and Biotechnology . Artificial Cells, Nanomedicine and Biotechnology covers the frontiers of interdisciplinary research and application, combining artificial cells, nanotechnology, nanobiotechnology, biotechnology, molecular biology, bioencapsulation, novel carriers, stem cells and tissue engineering. Emphasis is on basic research, applied research, and clinical and industrial applications of the following topics: -artificial cells -blood substitutes and oxygen therapeutics -nanotechnology, nanobiotechnology, nanomedicine -tissue engineering -stem cells -bioencapsulation -microencapsulation and nanoencapsulation -microparticles and nanoparticles -liposomes -cell therapy and gene therapy -enzyme therapy -drug delivery systems -biodegradable and biocompatible polymers for scaffolds and carriers -biosensors -immobilized enzymes and their uses -other biotechnological and nanobiotechnological approaches Rapid progress in modern research cannot be carried out in isolation and is based on the combined use of the different novel approaches. The interdisciplinary research involving novel approaches, as discussed above, has revolutionized this field resulting in rapid developments. This journal serves to bring these different, modern and futuristic approaches together for the academic, clinical and industrial communities to allow for even greater developments of this highly interdisciplinary area.
| YEAR | Impact Factor |
|---|---|
| 2023-24 | 4.5 |
| 2022 | 5.8 |
| 2021 | 6.355 |
Artificial Cells Nanomedicine and Biotechnology, 2169-141X, 2013-ongoing, Biochemistry, Genetics and Molecular Biology,Engineering,Medicine.